Assembly Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.38
|
|
Average Rating
|
3.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.47
|
-0.48
|
-0.01
|
-2.13%
|
|
2022-06-30
|
-0.47
|
-0.51
|
-0.04
|
-8.51%
|
|
2022-03-31
|
-0.47
|
-0.48
|
-0.01
|
-2.13%
|
|
2021-12-31
|
-0.48
|
-0.38
|
0.10
|
20.83%
|
|
2021-09-30
|
-0.56
|
-0.41
|
0.15
|
26.79%
|
|
2021-06-30
|
-0.66
|
-0.55
|
0.11
|
16.67%
|
|
2021-03-31
|
-0.79
|
-0.69
|
0.10
|
12.66%
|
|
2020-12-31
|
-0.90
|
-0.96
|
-0.06
|
-6.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.47
|
|
2021-12-31
|
-2.03
|
|
2020-12-31
|
-1.62
|
|
2019-12-31
|
-3.72
|
|
2018-12-31
|
-4.00
|
|
2017-12-31
|
-2.46
|
|
2016-12-31
|
-2.57
|
|
2015-12-31
|
-1.88
|
|
2014-12-31
|
-3.68
|
|
2013-12-31
|
-3.84
|
|
2012-12-31
|
-9.70
|
|
2011-12-31
|
-18.15
|
|
2010-12-31
|
-118.00
|